Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)
Author
Wiendl, H.
Comi, G.
Van Wijmeersch, B.
Buffels, R.
Wei, W.
Vermersch, P.
Eralinna, J.
Nicholas, R.
Oreja-Guevara, C.
Siva, A.
Metadata
Show full item recordCollections
- Bildiri [64839]